The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((2-(thiophen-2-yl)thiazol-4-yl)methyl)-2H-chromene-3-carboxamide ID: ALA1673318
PubChem CID: 2738825
Max Phase: Preclinical
Molecular Formula: C18H14N2O2S2
Molecular Weight: 354.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: SCR 01311 | CHEMBL1673318|ZINC01034831|Maybridge3_006006|HMS1448A22|BDBM50336527|CCG-42327|SCR 01311|IDI1_017393|NS00097903|SR-01000004523|SR-01000004523-1|SR-01000004523-2|N-((2-(thiophen-2-yl)thiazol-4-yl)methyl)-2H-chromene-3-carboxamide
Canonical SMILES: O=C(NCc1csc(-c2cccs2)n1)C1=Cc2ccccc2OC1
Standard InChI: InChI=1S/C18H14N2O2S2/c21-17(13-8-12-4-1-2-5-15(12)22-10-13)19-9-14-11-24-18(20-14)16-6-3-7-23-16/h1-8,11H,9-10H2,(H,19,21)
Standard InChI Key: YBHLYRJZHRTXQB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
12.1739 0.6848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8903 1.0980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8874 1.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1721 2.3376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4591 1.0976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4633 1.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7528 2.3399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0336 1.9321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0295 1.1048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7445 0.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3126 0.6967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6007 1.1134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3076 -0.1283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8838 0.7053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1718 1.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0909 1.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2851 2.1172 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.8683 1.4053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4166 0.7888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0432 1.3933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5524 2.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7715 1.7855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7834 0.9606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5716 0.7170 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
11 12 1 0
5 1 1 0
11 13 2 0
2 3 1 0
12 14 1 0
14 15 1 0
18 19 2 0
3 4 2 0
16 17 1 0
4 6 1 0
5 10 1 0
6 7 1 0
15 16 2 0
17 18 1 0
19 15 1 0
7 8 1 0
18 20 1 0
23 24 1 0
8 9 1 0
21 22 1 0
9 10 2 0
5 6 2 0
9 11 1 0
20 21 2 0
22 23 2 0
24 20 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.46Molecular Weight (Monoisotopic): 354.0497AlogP: 3.96#Rotatable Bonds: 4Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.30CX LogP: 3.30CX LogD: 3.30Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.77Np Likeness Score: -1.89
References 1. King-Keller S, Li M, Smith A, Zheng S, Kaur G, Yang X, Wang B, Docampo R.. (2010) Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas' disease., 54 (9): [PMID:20625148 ] [10.1128/aac.00313-10 ]